The new reality: Hims as an incubator, Bonobos as an M&A shop, and Harry’s as a VC. What’s driving this new DNVB trend?
Subscriber Phil Soriano explores why some of today’s VC-backed ‘blue chip’ DNVBs are engaging in some unusual activity beyond the scope of brand and community development. In some way or another, the likes of Glossier, Harry’s, Bonobos, and Hims have each dabbled in acquisitions, incubation, or in-house VC expansion. Soriano explains why.
A $200M valuation, TV commercials, and billboards: A closer (critical) look at how Hims is fast-tracking the modern luxury playbook.
The men’s wellness upstart is (wisely) fast-tracking the DNVB playbook, but we’re worried whether a $200M valuation is justified for a consumer-facing brand that’s only four months into business.
Care/of scoops up $12M in a new Series A, its second fundraise since November.
At this point, at least in terms of valuation and momentum, it’s easy to argue that Care/of is currently king of the hill in the new emerging premium supplements and vitamins space.
Still not sure what a DNVB is? This new white paper should help you out.
Since introducing the term in 2016, Andy Dunn’s DNVB acronym has caught on. A new white paper adds more depth to the conversation. (609 words)
